Psychiatry - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study
    Kirschner, M ; Hodzic-Santor, B ; Antoniades, M ; Nenadic, I ; Kircher, T ; Krug, A ; Meller, T ; Grotegerd, D ; Fornito, A ; Arnatkeviciute, A ; Bellgrove, MA ; Tiego, J ; Dannlowski, U ; Koch, K ; Huelsmann, C ; Kugel, H ; Enneking, V ; Klug, M ; Leehr, EJ ; Boehnlein, J ; Gruber, M ; Mehler, D ; DeRosse, P ; Moyett, A ; Baune, BT ; Green, M ; Quide, Y ; Pantelis, C ; Chan, R ; Wang, Y ; Ettinger, U ; Debbane, M ; Derome, M ; Gaser, C ; Besteher, B ; Diederen, K ; Spencer, TJ ; Fletcher, P ; Roessler, W ; Smigielski, L ; Kumari, V ; Premkumar, P ; Park, HRP ; Wiebels, K ; Lemmers-Jansen, I ; Gilleen, J ; Allen, P ; Kozhuharova, P ; Marsman, J-B ; Lebedeva, I ; Tomyshev, A ; Mukhorina, A ; Kaiser, S ; Fett, A-K ; Sommer, I ; Schuite-Koops, S ; Paquola, C ; Lariviere, S ; Bernhardt, B ; Dagher, A ; Grant, P ; van Erp, TGM ; Turner, JA ; Thompson, PM ; Aleman, A ; Modinos, G (SPRINGERNATURE, 2022-02)
    Neuroanatomical abnormalities have been reported along a continuum from at-risk stages, including high schizotypy, to early and chronic psychosis. However, a comprehensive neuroanatomical mapping of schizotypy remains to be established. The authors conducted the first large-scale meta-analyses of cortical and subcortical morphometric patterns of schizotypy in healthy individuals, and compared these patterns with neuroanatomical abnormalities observed in major psychiatric disorders. The sample comprised 3004 unmedicated healthy individuals (12-68 years, 46.5% male) from 29 cohorts of the worldwide ENIGMA Schizotypy working group. Cortical and subcortical effect size maps with schizotypy scores were generated using standardized methods. Pattern similarities were assessed between the schizotypy-related cortical and subcortical maps and effect size maps from comparisons of schizophrenia (SZ), bipolar disorder (BD) and major depression (MDD) patients with controls. Thicker right medial orbitofrontal/ventromedial prefrontal cortex (mOFC/vmPFC) was associated with higher schizotypy scores (r = 0.067, pFDR = 0.02). The cortical thickness profile in schizotypy was positively correlated with cortical abnormalities in SZ (r = 0.285, pspin = 0.024), but not BD (r = 0.166, pspin = 0.205) or MDD (r = -0.274, pspin = 0.073). The schizotypy-related subcortical volume pattern was negatively correlated with subcortical abnormalities in SZ (rho = -0.690, pspin = 0.006), BD (rho = -0.672, pspin = 0.009), and MDD (rho = -0.692, pspin = 0.004). Comprehensive mapping of schizotypy-related brain morphometry in the general population revealed a significant relationship between higher schizotypy and thicker mOFC/vmPFC, in the absence of confounding effects due to antipsychotic medication or disease chronicity. The cortical pattern similarity between schizotypy and schizophrenia yields new insights into a dimensional neurobiological continuity across the extended psychosis phenotype.
  • Item
    Thumbnail Image
    Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD working group
    Leerssen, J ; Blanken, TF ; Pozzi, E ; Jahanshad, N ; Aftanas, L ; Andreassen, OA ; Baune, BT ; Ching, CRK ; Dannlowski, U ; Frodl, T ; Godlewska, BR ; Gotlib, IH ; Grotegerd, D ; Gruber, O ; Hatton, SN ; Hickie, IB ; Jaworska, N ; Kircher, T ; Krug, A ; Lagopoulos, J ; Li, M ; MacMaster, FP ; McIntosh, AM ; Mwangi, B ; Osipov, E ; Portella, MJ ; Sacchet, MD ; Samann, PG ; Simulionyte, E ; Soares, JC ; Walter, M ; Whalley, HC ; Veltman, DJ ; Thompson, PM ; Schmaal, L ; Van Someren, EJW (WILEY, 2020-09)
  • Item
    Thumbnail Image
    Genome-wide association study of circulating interleukin 6 levels identifies novel loci
    Ahluwalia, TS ; Prins, BP ; Abdollahi, M ; Armstrong, NJ ; Aslibekyan, S ; Bain, L ; Jefferis, B ; Baumert, J ; Beekman, M ; Ben-Shlomo, Y ; Bis, JC ; Mitchell, BD ; de Geus, E ; Delgado, GE ; Marek, D ; Eriksson, J ; Kajantie, E ; Kanoni, S ; Kemp, JP ; Lu, C ; Marioni, RE ; McLachlan, S ; Milaneschi, Y ; Nolte, IM ; Petrelis, AM ; Porcu, E ; Sabater-Lleal, M ; Naderi, E ; Seppala, I ; Shah, T ; Singhal, G ; Standl, M ; Teumer, A ; Thalamuthu, A ; Thiering, E ; Trompet, S ; Ballantyne, CM ; Benjamin, EJ ; Casas, JP ; Toben, C ; Dedoussis, G ; Deelen, J ; Durda, P ; Engmann, J ; Feitosa, MF ; Grallert, H ; Hammarstedt, A ; Harris, SE ; Homuth, G ; Hottenga, J-J ; Jalkanen, S ; Jamshidi, Y ; Jawahar, MC ; Jess, T ; Kivimaki, M ; Kleber, ME ; Lahti, J ; Liu, Y ; Marques-Vidal, P ; Mellstrom, D ; Mooijaart, SP ; Muller-Nurasyid, M ; Penninx, B ; Revez, JA ; Rossing, P ; Raikkonen, K ; Sattar, N ; Scharnagl, H ; Sennblad, B ; Silveira, A ; St Pourcain, B ; Timpson, NJ ; Trollor, J ; van Dongen, J ; Van Heemst, D ; Visvikis-Siest, S ; Vollenweider, P ; Volker, U ; Waldenberger, M ; Willemsen, G ; Zabaneh, D ; Morris, RW ; Arnett, DK ; Baune, BT ; Boomsma, D ; Chang, Y-PC ; Deary, IJ ; Deloukas, P ; Eriksson, JG ; Evans, DM ; Ferreira, MA ; Gaunt, T ; Gudnason, V ; Hamsten, A ; Heinrich, J ; Hingorani, A ; Humphries, SE ; Jukema, JW ; Koenig, W ; Kumari, M ; Kutalik, Z ; Lawlor, DA ; Lehtimaki, T ; Marz, W ; Mather, KA ; Naitza, S ; Nauck, M ; Ohlsson, C ; Price, JF ; Raitakari, O ; Rice, K ; Sachdev, PS ; Slagboom, E ; Sorensen, TIA ; Spector, T ; Stacey, D ; Stathopoulou, MG ; Tanaka, T ; Wannamethee, SG ; Whincup, P ; Rotter, J ; Dehghan, A ; Boerwinkle, E ; Psaty, BM ; Snieder, H ; Alizadeh, BZ (OXFORD UNIV PRESS, 2021-03-01)
    Interleukin 6 (IL-6) is a multifunctional cytokine with both pro- and anti-inflammatory properties with a heritability estimate of up to 61%. The circulating levels of IL-6 in blood have been associated with an increased risk of complex disease pathogenesis. We conducted a two-staged, discovery and replication meta genome-wide association study (GWAS) of circulating serum IL-6 levels comprising up to 67 428 (ndiscovery = 52 654 and nreplication = 14 774) individuals of European ancestry. The inverse variance fixed effects based discovery meta-analysis, followed by replication led to the identification of two independent loci, IL1F10/IL1RN rs6734238 on chromosome (Chr) 2q14, (Pcombined = 1.8 × 10-11), HLA-DRB1/DRB5 rs660895 on Chr6p21 (Pcombined = 1.5 × 10-10) in the combined meta-analyses of all samples. We also replicated the IL6R rs4537545 locus on Chr1q21 (Pcombined = 1.2 × 10-122). Our study identifies novel loci for circulating IL-6 levels uncovering new immunological and inflammatory pathways that may influence IL-6 pathobiology.